Aura Biosciences, Inc. (AURA) Free cash flow 2020–2025
Aura Biosciences, Inc. (AURA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$85.2MFY2025 · since FY2020: -$25.1M → -$85.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.2M | -5.1% |
| FY2024 | -$81.1M | -25.6% |
| FY2023 | -$64.6M | -15.9% |
| FY2022 | -$55.7M | -61.3% |
| FY2021 | -$34.5M | -37.6% |
| FY2020 | -$25.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice